NeoRecormon (epoetin beta)

NeoRecormon contains the active substance epoetin beta and is a medicine that stimulates the growth of red blood cells. It is indicated for the treatment of patients with anaemia due to chronic kidney disease (CKD), or chemotherapy-induced anaemia (when treating certain cancers). It is also used to prevent anaemia in premature babies, or for patients where blood will be extracted before they undergo surgery.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeCovid-19Pharma solutionsRoche careersMedia libraryAnnual Report 2023Privacy policyLegal statement